Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Under the responsibility of the directorate general for health
For high-volume biopharmaceutical applications
There has been considerable progress in the application of single-use technologies in biopharmaceutical production. CMO Rentschler Biotechnologie discusses recent advances
Will invest US$200m to expand production at Janssen Pharmaceutical Companies
Will build modern research infrastructure, attractive offices and develop a sustainable site
Armin Dalluege, General Manager of Wasserburger Arzneimittelwerk, a subsidiary of Recipharm, in Wasserburg, Germany, highlights trends in drug lyophilisation
The project is awarded US$12.2m by US Defense Advanced Research Projects Agency (DARPA)
With an increase in the number of innovator companies looking to outsource the development and manufacture of mPEGs, Dr. Reddy’s (CPS) discusses what to look for in a potential outsourcing partner
They will study the extraction, stabilisation and crystallisation of full-length human ABC transporters
With regulatory pressure mounting, pharma companies should need no help deciding to migrate to paperless trial master files. For those thinking about switching, Rik van Mol, Vice President of R&D Strategy, Veeva Systems, outlines the key considerations for making the transition
Makes it easier for industrial and pharmaceutical labs to test for product safety
The clinical supply chain involves working with several outsourced partners. Jens Mattuschka, Vice President, CLS Worldwide Operations, Parexel International, looks at core planning to reduce the risk of failure